Search research articles
Contact Us
Filters
Showing results (181-190 of 197) with videos related to
Page
of 20
Sort By:
Current Medicinal Chemistry
|
January 2, 2013
Deregulation of HOX B13 expression in urinary bladder cancer progression
L Marra, M Cantile, G Scognamiglio, et al.
British Journal of Cancer
|
August 25, 2011
Expression and functional role of CRIPTO-1 in cutaneous melanoma
A De Luca, L Lamura, L Strizzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2003
Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting for MLH1 and MSH2 inactivation in familial cases
M Colombino, A Cossu, A Arba, et al.
The British Journal of Dermatology
|
November 22, 2007
Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma
M C Sini, A Manca, A Cossu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay
G Palmieri, P A Ascierto, A Cossu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2007
Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study
A Sapino, F Montemurro, C Marchiò, et al.
Cancer Research
|
September 29, 1998
Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma
G Chiappetta, G Tallini, M C De Biasio, et al.
British Journal of Cancer
|
April 20, 2006
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial
C Pacilio, A Morabito, F Nuzzo, et al.
Minerva Medica
|
January 17, 1970
[Use of 17,21-di-monochloroacetyl-ajmaline in the prevention and therapy of arrhythmia caused by myocardial hyperexcitability]
M Bossi, G Botti, S Campus, et al.
Bollettino Della Societa Italiana Di Cardiologia
|
January 1, 1980
[Validity of the study of the electrophysiological effects of anti-arrhythmia drugs in man prior to modern antiarrhythmic therapy. Multicenter study]
M Disertori, F Furlanello, G Botti, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 197) with videos related to
Sort By:
Page
of 20
Current Medicinal Chemistry
|
January 2, 2013
Deregulation of HOX B13 expression in urinary bladder cancer progression
L Marra, M Cantile, G Scognamiglio, et al.
British Journal of Cancer
|
August 25, 2011
Expression and functional role of CRIPTO-1 in cutaneous melanoma
A De Luca, L Lamura, L Strizzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2003
Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting for MLH1 and MSH2 inactivation in familial cases
M Colombino, A Cossu, A Arba, et al.
The British Journal of Dermatology
|
November 22, 2007
Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma
M C Sini, A Manca, A Cossu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay
G Palmieri, P A Ascierto, A Cossu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2007
Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study
A Sapino, F Montemurro, C Marchiò, et al.
Cancer Research
|
September 29, 1998
Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma
G Chiappetta, G Tallini, M C De Biasio, et al.
British Journal of Cancer
|
April 20, 2006
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial
C Pacilio, A Morabito, F Nuzzo, et al.
Minerva Medica
|
January 17, 1970
[Use of 17,21-di-monochloroacetyl-ajmaline in the prevention and therapy of arrhythmia caused by myocardial hyperexcitability]
M Bossi, G Botti, S Campus, et al.
Bollettino Della Societa Italiana Di Cardiologia
|
January 1, 1980
[Validity of the study of the electrophysiological effects of anti-arrhythmia drugs in man prior to modern antiarrhythmic therapy. Multicenter study]
M Disertori, F Furlanello, G Botti, et al.
Page
of 20